US 9878031
Compositions, methods of administration and uses for trivalent dengue virus formulations
granted A61KA61K2039/5254A61K2039/5256
Quick answer
US patent 9878031 (Compositions, methods of administration and uses for trivalent dengue virus formulations) held by Takeda Vaccines, Inc. expires Mon Jan 25 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Vaccines, Inc.
- Grant date
- Tue Jan 30 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 25 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K2039/5254, A61K2039/5256, A61K2039/70, A61K39/12